New Zealand’s Fisher & Paykel Healthcare hikes 2027 profit guidance

Fisher & Paykel Healthcare has increased its profit guidance for 2027, leading to a positive reaction in the financial markets. This upward revision of future earnings expectations has directly contributed to the rise in the company's stock price today. Investors are responding favorably to the updated financial outlook provided by the New Zealand based healthcare firm, which signals stronger growth projections and improved profitability for the organization over the coming years in its global operations.